Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
Partial adherence and nonadherence to medication continue to be problems in the treatment of patients with schizophrenia. Nonadherence to medication has a negative impact on the course of illness for these patients as is shown by data on relapse, rehospitalization, time to remission, and attempted suicide. Several factors that contribute to poor adherence have been identified and need to be taken into account when attempting to address the problem of nonadherence. These risk factors relate to the patient, his or her illness and social situation, and the physician. Among the measures that have the potential to improve adherence to medication are psychosocial interventions, psychoeducation in the form of professional, peer-to-peer or family-to-family interventions, and shared decision making.
Leucht
Stefan
S
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum rechts der Isarder, Technischen Universität München, Ismaningerstrasse 22, 81675 Munich, Germany. stefan.leucht@lrz.tu-muenchen.de
Heres
Stephan
S
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005196:Family Therapy; D006801:Humans; D017063:Outcome Assessment, Health Care; D010353:Patient Education as Topic; D010358:Patient Participation; D010359:Patient Readmission; D011368:Professional-Family Relations; D011379:Prognosis; D011613:Psychotherapy / Q000379:methods*; D012008:Recurrence; D012307:Risk Factors; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy*; D012565:Schizophrenic Psychology; D013406:Suicide, Attempted / Q000706:statistics & numerical data; D016896:Treatment Outcome; D016312:Treatment Refusal / Q000523:psychology / Q000706:statistics & numerical data*
D014150:Antipsychotic Agents